As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

Johnson & Johnson (JNJ) announced that its subsidiary, Red River Talc LLC, has voluntarily filed for a prepackaged Chapter 11 ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...

Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

The past 15 months have been challenging regarding treatment for my ovarian cancer. But today, my goal is to focus on healing ...

Ovarian cancer is a type of cancer that impacts the female reproductive system. The risk of developing ovarian cancer in a woman's lifetime is 1 in 87, according to the American Cancer Society (ACS).

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

HAMPTON TOWNSHIP, Pa. (KDKA) -- The National Ovarian Cancer Coalition Great Lakes chapter held its biggest fundraiser of the ...

Researchers investigated RA51C and uncovered over 3,000 harmful genetic changes that could increase cancer risk.